Journal:Quality control in the clinical biochemistry laboratory: A glance

Full article title	Quality control in the clinical biochemistry laboratory: A glance
Journal	Journal of Clinical and Diagnostic Research
Author(s)	Naphade, Manoj; Ankur, Panchbudhe S.; Rajendra, Shivkar R.
Author affiliation(s)	Kiran Medical College, Smt. Kashibai Navale Medical College and General Hospital
Primary contact	drnmanoj at gmail dot com
Year published	2023
Volume and issue	17(2)
Article #	BE01 - BE04
DOI	10.7860/JCDR/2023/58635.17447
ISSN	0973-709X
Distribution license	Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
Website	https://www.jcdr.net//article_fulltext.asp
Download	https://www.jcdr.net//articles/PDF/17447/58635_CE(AD)_F(IS)_PF1(AKA_SS)_PFA(SS)_PN(SS).pdf (PDF)

Abstract

Quality control (QC) is a process, designed to ensure reliable test results. It is part of overall laboratory quality management in terms of accuracy, reliability, and timeliness of reported test results. Two types of QC are exercised in clinical biochemistry: internal QC (IQC) and external quality assurance (QA). IQC represents the quality methods performed every day by laboratory personnel with the laboratory’s materials and equipment. It primarily checks the precision (i.e., repeatability or reproducibility) of the test method. External quality assurance service (EQAS) is performed periodically (i.e., every month, every two months, twice a year) by the laboratory personnel, who primarily are checking the accuracy of the laboratory’s analytical methods. Consequences of inaccurate results could be unnecessary treatment, treatment complications, failure to provide the proper treatment, delay in correct diagnosis, additional and unnecessary diagnostic testing, leading to increased healthcare costs (in terms of time and personnel effort) and often in poor patient outcomes. By running QC, a laboratory self-monitors its testing process and substantiates that the results produced are accurate and precise. The lab's quality management system (QMS), looking at every aspect of the laboratory from sample collection to result dispatch, is very important for achieving and maintaining good laboratory performance. A QC program allows the laboratory to differentiate between normal variation and error. This review article outlines the indispensable role of QC in the clinical biochemistry laboratory, which ensures patient satisfaction, ensures the credibility of the laboratory, generates confidence in laboratory results, and reduces unnecessary financial burden.

Keywords: accuracy, error, precision, quality control, quality management

Introduction

Laboratory investigations are indispensable tools in the healthcare delivery system. Patient-based laboratory testing is used for confirmation of diagnosis, as well as to monitor the progress of the patient and response to the treatment. [1] In today’s era of evidence-based medicine, a clinical laboratory acts like a platform on which all departments rely for timely delivery of patient care. [1] Upwards of 70 percent of clinical decisions are made with the help of diagnostic tests. [2]

A clinical sample (i.e., specimen) goes through three phases before a report confirming results is generated: pre-analytical, analytical, and post-analytical. [3] The pre-analytical phase involves all the steps before a sample is acknowledged by the laboratory, ranging from ordering of the test, patient preparation, sample collection, transportation, accession, and specimen preparation. The analytical phase refers to the processing or analysis of the sample using an autoanalyzer or standardized method. Finally, the post-analytical phase starts after a result/signal is received from an instrument and recorded (either automatically via laboratory information system [LIS] or manually via transcribing the report), interpreted by the physician, and further followed-up with the patient. [3]

Sources of laboratory errors

Within these three phases, there are a number of possible errors that can affect the quality of the clinical laboratory output. To improve quality, all three phases can be targeted individually, although it is well published that most errors occur in the pre- and post-analytical phases. [4–6] We examine each phase to see which errors are most common to each.

Pre-analytical errors

Common problems encountered and their possible resolutions in the pre-analytical phase are as follows [1]:

• Ordering investigations: Physicians should make an informed and conscious choice before ordering a test, keeping in mind the relevance for correct diagnosis, as well as the irrelevance of tests that may not add to the already available clinical knowledge concerning the patient. [1]
• Incomplete laboratory request forms: Legibility and completeness of the form are important to ensure the correct analyses are performed. For example, age or gender of the person may not be mentioned on the form, leading to an ill-advised test for that age or gender being used. [1]
• Patient preparation: Certain tests require a few precautions or steps of preparation be followed by the patient. For example, some tests require that the patient be fasting, such as blood glucose and lipid profile analyses. There may also be special timing issues for tests such as drug levels and hormone tests. This needs to be addressed to ensure that a reliable result is generated in the end since an error at this phase makes the following steps of analysis and interpretation irrelevant, even if performed to perfection. [1]
• Specimen collection (potential outcomes of collection errors): Incorrect phlebotomy practices and patient information can lead to an inadequate quantity of sample collection. For example, lipemic or hemolyzed samples make their further processing difficult or impossible and lead to subsequent unreliable results. Blood tests might require serum, plasma, or whole blood. Other tests might require urine or saliva. [7]
• Wrong patient-specimen identification/wrong labelling of the containers: Patient identification errors before sample collection account for up to 25 percent of all pre-analytical errors. [8] This can lead to patients being diagnosed and treated based on a sample from another patient. If not identified or correlated, outcomes can be catastrophic.
• Transportation: The conditions and time between sample collection and analysis, if not followed properly, are enough to affect certain analyses’ values.
• Errors in specimen preparation: The time spent processing the sample—including centrifugation speed and temperature, light exposure, and aliquot preparation—are critical considerations that must be weighed before sample processing is carried out. Not properly processing a specimen before the test, or the introduction of substances which interfere with test performance, may affect analytical results. [9]
• Limitations in reducing preanalytical errors: A more significant pre-analytical error source is biological variance, not linked to and uncontrollable by human error. [1]

Pre-analytical errors can be minimized by checking the test requisition form, the name of the patient on the vacutainer, and the requested tests. The implementation of barcode technology for specimen identification has been the major advance in the automation of the laboratory. A barcode label generated by a LIS can be read by one or more barcode readers placed in key positions in the analytical system. Barcode technology has the advantages of not requiring work lists for the workflow and preventing the mix-up of tubes in analyzers during sampling. [10] Pre-analytical errors can also be kept in check by working with the patient regarding food intake, alcohol intake, any drug usage, smoking, etc., as these factors may influence the result. Aside from instructing patients properly for the collection of the sample, the clinical lab can [7]:

• confirm the use of correct anticoagulant and the adequate amount of sample;
• inspect the serum for hemolysis or lipemic index;
• record the time at which the sample is received and when the report is ready and dispatched; and
• observe standard operating procedures (SOPs) for sample processing, as even time of separation, centrifuge speed, and the temperature at which a sample gets separated are important.

Analytical errors

Reliable test results can be achieved by a careful selection, evaluation, and implementation of analytical methods for investigations. Equipment, reagents, and consumables make up integral parts of the analytical process. A good equipment management system helps to maintain a high level of laboratory performance; reduces variation in test results, while improving the technologist’s confidence in the accuracy of testing results; and lowers repair costs, while reducing interruption of services due to breakdowns and failures. Improved quality and reproducibility of test results is also one of the biggest advantage of using automation in the analytical phase by minimizing errors due to carry-over of samples and inadequate sample mix up. [11] One of the goals of QC is to differentiate between normal variation and errors.

Common problems encountered in the analytical phase include:

• Reference ranges: While reporting results, laboratories should have well-established reference ranges based on physiological parameters such as age, the period of gestation in case of pregnancy, and gender (rather than ambiguous and general ones), as the interpreting physician will be treated based on these ranges provided. [7]
• Participation without action: Although the lab participates in quality programs, until and unless they use the information received through that participation, mere participation will not help improve analytical errors.
• Verify test performance: For any laboratory test parameter, its performance should be evaluated and verified with respect to its sensitivity, specificity, linearity, and precision.
• Total allowable error (TEa): Errors that occur during the analytical phase could be either random or systematic. TEa sets a limit for combined imprecision (random error) and bias (inaccuracy, or systematic error) that are tolerable in a single measurement or single test result to ensure clinical usefulness of that particular result. Defining the allowable error is important for high accuracy and precision of the analytical process. [12–13]

Analytical errors can be kept down by use of auto-analyzers for analysis of test parameters, ensuring the validity and acceptability of a new program, instrument, and technique for a particular test. They can also be minimized by verifying the reportable range, precision, analytical sensitivity, interferences, and accuracy, as provided by the test-specific kit insert. Analytical errors can also be held in check by using reference ranges specific to the physiological conditions of the patients, such as age, gender, and gestation, in case of pregnancy. These reference ranges should be verified by running samples of healthy individuals. Other things the lab can do include:

• scheduling daily and monthly preventive maintenance for each instrument;
• checking water quality, power supply, calibration of electrical balance, and calibration of glassware and pipettes;
• maintaining records of date for reagents and kits when received and when opened,
• running new lots of the reagents with the old lot in parallel before being used for analysis; and
• monitoring QC using internal QC (IQC) and external quality assurance service (EQAS) programs.

Notes

This presentation is faithful to the original, with changes to presentation, spelling, and grammar as needed. The PMCID and DOI were added when they were missing from the original reference. No other changes were made in accordance with the "NoDerivatives" portion of the content license.